Are you Dr. Castro?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 50 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3300 Gallows Rd
Falls Church, VA 22042Phone+1 703-776-3111Fax+1 904-346-0113
Summary
- Dr. Elena Castro, MD is a board certified emergency medicine physician in Falls Church, Virginia. She is currently licensed to practice medicine in Virginia, District of Columbia, and Maryland.
Education & Training
- University of Florida College of Medicine JacksonvilleResidency, Emergency Medicine, 2003 - 2006
- Georgetown University School of MedicineClass of 2003
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- DC State Medical License 2015 - 2027
- MD State Medical License 2008 - 2026
- VA State Medical License 2006 - 2016
- FL State Medical License 2006 - 2012
- American Board of Emergency Medicine Emergency Medicine
Publications & Presentations
PubMed
- 13 citationsEvidence for altered host genetic factors in KSHV infection and KSHV-related disease development.Melissa J. Blumenthal, Elena M. Cornejo Castro, Denise Whitby, Arieh A. Katz, Georgia Schäfer
Reviews in Medical Virology. 2021-03-01 - 21 citationsDistinct genetic architectures and environmental factors associate with host response to the γ2-herpesvirus infections.Neneh Sallah, Wendell Miley, Nazzarena Labo, Tommy Carstensen, Segun Fatumo
Nature Communications. 2020-07-31 - 8 citationsDual infection and recombination of Kaposi sarcoma herpesvirus revealed by whole-genome sequence analysis of effusion samplesElena M. Cornejo Castro, Vickie Marshall, Justin B. Lack, Kathryn Lurain, Taina T. Immonen
Virus Evolution. 2020-06-30
Press Mentions
- Adding Talazoparib to Enzalutamide Extends Progression-Free Survival in Metastatic Castration-Resistant Prostate CancerFebruary 20th, 2023
- PARP-inhibitor Combination Prolongs Progression-Free Survival in Metastatic Prostate CancerFebruary 17th, 2023
- Adding Enzalutamide to ADT Plus AAP Unnecessary in Metastatic HSPCSeptember 11th, 2022
- Join now to see all